Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: It is what it is and always has been

i would suggest that if ptsc had continued

a modest annual dividend instead of underfunded speculative investments

in companies they had no special expertise in, the stock price would have held

up better.

But they wouldn't have continued with a "modest regular dividend. " There was no incentive. There is no reason to suspect that they would have done this and in fact they didn't well before they made their unwise investments.

I disliked against the non-MMP investments as much as anyone and criticized them openly. The best use of cash would have been sitting on it. Not dividends. Not venture capital.

Would shareholders rather have a piece of the money wasted on spurious investments? Sure. But not making those investments does not guarantee that shareholders would have received that money as dividends. Surely our esteemed BOD would have found another way to reward cronies. This has never been about shareholders. Anything shareholders get are crumbs off the table.

Share
New Message
Please login to post a reply